Latest: Watch here for details of new products and services.
- About Us
- Pharmalicensing - Open Innovation for the life sciences
- Our Products
- Overview
- Partnering Search
- Company Profiling
- Partneringtools
- Reports
- Partnering Consulting
- Due Diligence
- Comparison
- Due Diligence
- Overview
- Top Applications
- Online Panel Discussions
- Request Consultation
- Case Studies
- See what others think about our service
- Newsletter
- Partnering update
- Key reports
- Subscribe
- Quick Links
- Profile now
- Register now
- Profiled companies
- Featured events
- Industry news
- PR Newswire
- Jobs
- Forums
- Contact Pharmalicensing
- Send an email
- Call us: +44 1904 520460
- Request a callback
- RSS Feeds
- Keep up to date
Pharmalicensing Ltd
is a division of
is a division of
- Companies
- Browse
Companies
Alliance pharmaceuticals is a dynamic UK pharmaceutical company with a successful acquisition and partnership track record More
King's College London Business Ltd is responsible for commercialisation of technologies emanating from King's. Opportunities include: Collaborative & Contract research, Consultancy, Clinical trials. More
LBN was established in June 2000, providing the first co-ordinated approach to biotechnology in London. With over 2000 members, LBN is now one of the largest biotechnology networks in Europe. More
LeadDiscovery offers intelligence services to the drug discovery sector. Focusing on pre-clinical research and analysis for identification and development of new therapeutic entities More
Genecom is the commercialisation arm of the Moredun Institute and the Institute for Animal Health. These institutes have international reputations in the area of animal health. More
GW Pharmaceuticals develops a range of medicines based on cannabinoids and other controlled drugs More
Encap is an international drug delivery solutions provider with fully integrated capabilities in drug delivery, contract development and commercial manufacture. More
Zapaloid uses proprietary technology to develop innovative disease-modifying therapeutic strategies against protein misfolding diseases, such as Type 2 diabetes, Parkinson's and Alzheimer's disease More
Your selection
Browse By
- Industry sector
- Academic/Research
- Animal health
- Biotechnology
- Diagnostic
- Drug delivery
- Drug discovery
- Medical device
- Non-profit org./Government
- Pharmaceutical
- Research tools
- Service
- Therapeutic target
- Anorexia
- Anti-oxidant
- Appetite
- Bulimia nervosa
- Cachexia
- Cirrhosis
- Diabetes type I
- Diabetes type II
- Diabetic complications
- Fabry's disease
- Gallbladder disorder (other)
- Gallstones
- Gaucher's disease
- Hepatic protectors
- Hepatic protectors
- Hypercholesterolemia
- Hyperparathyroidism
- Hypertriglyceridemia
- Liver cancer
- Liver disorders (other)
- Metabolic disorder (other)
- Mineral supplement
- Obesity
- Weight loss
© Copyright 1995-2008 Pharmalicensing Ltd, is a division of 
All rights reserved. Terms and Conditions | Site map | Contact us